NEO Stock Analysis: Neo Performance Materials | TO
Specialty Chemicals | TO, Canada | Market Cap: 1.210m CAD | 12M Return: 56.9% | CA64046G1063 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 6.22M
Qual. Beats: 0
Rev. Trend: -27.8%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 8.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Neo Performance Materials manufactures and sells rare-earth materials, magnetic powders and magnets, and rare-metal products across markets in Asia, North America, Europe, and elsewhere. Its three segments are Magnequench, Chemicals & Oxides, and Rare Metals.
Its materials serve applications including automotive, electronics, water treatment, aerospace, medical imaging, and clean energy. The company operates in the specialty materials sector, supplying processed materials used as components or inputs in other products. Founded in 1994, Neo is headquartered in Toronto, Canada.
- EV and appliance demand drives Magnequench magnetic powder sales
- China rare-earth controls reshape feedstock costs and supply
- European magnet plant investment adds execution and capital spending risk
| Net Income: 886k TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.13 > 0.02 and ΔFCF/TA -4.34 > 1.0 |
| NWC/Revenue: 46.10% < 20% (prev 41.23%; Δ 4.88% < -1%) |
| CFO/TA -0.10 > 3% & CFO -82.2m > Net Income 886k |
| Net Debt (70.2m) to EBITDA (94.2m): 0.75 < 3 |
| Current Ratio: 2.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.2m) vs 12m ago 6.73% < -2% |
| Gross Margin: 31.23% > 18% (prev 28.18%; Δ 3.05% > 0.5%) |
| Asset Turnover: 79.15% > 50% (prev 73.95%; Δ 5.21% > 0%) |
| Interest Coverage Ratio: 17.07 > 6 (EBIT TTM 79.1m / Interest Expense TTM 4.63m) |
| A: 0.32 (Total Current Assets 534.5m - Total Current Liabilities 259.2m) / Total Assets 856.5m |
| B: -0.08 (Retained Earnings -67.6m / Total Assets 856.5m) |
| C: 0.10 (EBIT TTM 79.1m / Avg Total Assets 754.5m) |
| D: 1.25 (Book Value of Equity 475.0m / Total Liabilities 381.0m) |
| Altman-Z'' = 3.86 = AA |
| DSRI: 1.21 (Receivables 149.1m/99.8m, Revenue 597.2m/482.5m) |
| GMI: 0.90 (GM 28.18% / 31.23%) |
| AQI: 0.76 (AQ_t 0.15 / AQ_t-1 0.19) |
| SGI: 1.24 (Revenue 597.2m / 482.5m) |
| TATA: 0.10 (NI 886k - CFO -82.2m) / TA 856.5m) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of November 12, 2026, the stock is trading at CAD 26.43 with a total of 255,121 shares traded. Over the past week, the price has changed by +7.00%, over one month by -1.97%, over three months by -32.37% and over the past year by +56.91%.
Current recommended Stop Loss: 22.40 (which is 15.2% or 2.5 ATR below the current price).
Neo Performance Materials has no consensus analysts rating.
Market Cap USD = 849.0m (1.21b CAD * 0.7017 CAD.USD)
P/E Trailing = 2619.0
P/E Forward = 13.4953
P/S = 2.0058
P/B = 1.8032
P/EG = 0.7933
Revenue TTM = 597.2m USD
EBIT TTM = 79.1m USD
EBITDA TTM = 94.2m USD
Long Term Debt = 103.3m USD (from longTermDebt, last quarter)
Short Term Debt = 54.8m USD (from shortTermDebt, last quarter)
Debt = 166.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 4.67m
Net Debt = 70.2m USD (calculated: Debt 166.3m - CCE 96.1m)
Enterprise Value = 919.2m USD (849.0m + Debt 166.3m - CCE 96.1m)
Interest Coverage Ratio = 17.07 (Ebit TTM 79.1m / Interest Expense TTM 4.63m)
EV/FCF = -8.39x (Enterprise Value 919.2m / FCF TTM -109.6m)
FCF Yield = -11.92% (FCF TTM -109.6m / Enterprise Value 919.2m)
FCF Margin = -18.35% (FCF TTM -109.6m / Revenue TTM 597.2m)
Net Margin = 0.15% (Net Income TTM 886k / Revenue TTM 597.2m)
Gross Margin = 31.23% ((Revenue TTM 597.2m - Cost of Revenue TTM 410.7m) / Revenue TTM)
Gross Margin QoQ = 35.64% (prev 31.37%)
Tobins Q-Ratio = 1.07 (Enterprise Value 919.2m / Total Assets 856.5m)
Interest Expense / Debt = 2.79% (Interest Expense 4.63m / Debt 166.3m)
Taxrate = 42.18% (12.4m / 29.4m)
NOPAT = 45.7m (EBIT 79.1m * (1 - 42.18%))
Current Ratio = 2.06 (Total Current Assets 534.5m / Total Current Liabilities 259.2m)
Debt / Equity = 0.35 (Debt 166.3m / totalStockholderEquity, last quarter 475.0m)
Debt / EBITDA = 0.75 (Net Debt 70.2m / EBITDA 94.2m)
Debt / FCF = -0.64 (negative FCF - burning cash) (Net Debt 70.2m / FCF TTM -109.6m)
Total Stockholder Equity = 412.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.12% (Net Income 886k / Total Assets 856.5m)
RoE = 0.21% (Net Income TTM 886k / Total Stockholder Equity 412.4m)
RoCE = 15.34% (EBIT 79.1m / Capital Employed (Equity 412.4m + L.T.Debt 103.3m))
RoIC = 7.35% (NOPAT 45.7m / Invested Capital 622.1m)
WACC = 9.60% (E(849.0m)/V(1.02b) * Re(11.17%) + D(166.3m)/V(1.02b) * Rd(2.79%) * (1-Tc(0.42)))
Discount Rate = 11.17% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 43.00 | Cagr: 3.75%
[DCF] Fair Price = unknown (Cash Flow -109.6m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.34 | # QB: 0
Revenue Correlation: -27.79 | Revenue CAGR: -2.86% | SUE: 0.90 | # QB: 1
EPS current Quarter (2027-03-31): EPS=0.33 | Chg30d=+1.54% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=1.44 | Chg30d=-2.48% | Revisions=+25% | GrowthEPS=+193.4% | GrowthRev=+48.4%
EPS next Year (2027-12-31): EPS=1.44 | Chg30d=-3.23% | Revisions=+25% | GrowthEPS=+0.2% | GrowthRev=+4.5%
[Analyst] Revisions Ratio: +50% (up=3, down=0)